Vivos (RDGL) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2017)
Vivos (RDGL) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.47% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 13.19% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.97% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 191.70% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -62.01% |
| Dec 31, 2016 | -53.77% |
| Sep 30, 2016 | -48.81% |
| Jun 30, 2016 | -45.56% |
| Mar 31, 2016 | -68.38% |
| Dec 31, 2015 | -72.59% |
| Sep 30, 2015 | -74.55% |
| Jun 30, 2015 | -75.14% |
| Mar 31, 2015 | -75.96% |
| Dec 31, 2014 | -76.47% |
| Sep 30, 2014 | -76.63% |
| Jun 30, 2014 | -76.75% |
| Dec 31, 2013 | -76.91% |